RedHawk Holdings Corp (fka SNDD)

[2times2]

IDNG OS 542M 02/06/2019; Unrestricted 287M

SEC Reporting/Audited Financials

Revenues in the pharmaceutical and medical device business unit are expected to improve as market acceptance of our products increases and we begin sales of our SANDD medical devices. Additionally, net profits are expected to improve as the Company’s pharmaceutical sales become more weighted to its branded generics which offer lower discounts than the discounts offered by the Company for its highly competitive “special” pharmaceuticals and require significantly lower operating costs. Additionally, our medical devices are being offered for sale at very attractive profit margins.
https://www.otcmarkets.com/filing/conv_pdf?id=13238157&guid=Q_ZtUqe4gPkDF3h

Law suit, which caused the pps drop over a year, settled 02//08/2019https://www.otcmarkets.com/stock/IDNG/disclosure - also leading to return of 52M shares to the treasury

List of subsidiaries:
100% owned by IDNG/REDHAWK:

1.RedHawk Land and Hospitality

2.RedHawk Medical Products & Service
(www.needledestructiondevice.com

3.RedHawk Medical Products UK
(http://redhawkmedical.co.uk)

4.RedHawk Pharma, LLC

5.EcoGen Europe LTD
(https://ecogen-europe.co.uk)

6.RedHawk Pharma UK LTD

7.RedHawk Financial Services, LLC

8.RedHawk Energy Corp., LLC
(http://redhawkenergycorp.com)

9.Centri Security Systems, LLC